Total Returns (Price + Dividend) 
Speciality Medi. for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News
Announcements 
Board Meeting Outcome for Outcome Of Board Meeting Held On November 12 2026 - Financial Result For The Half Year Ended On 30/09/2026
12-Nov-2026 | Source : BSEWe hereby inform you that the Board of Directors of the Company in their Board Meeting held on today i.e. on November 12 2026 at the Corporate Office of the Company which was commenced at 03:30 P.M. and concluded at 04:15 P.M. have apart from other businesses considered approved and taken on record the Unaudited Standalone Financial Results of the Company for the half year ended on September 30 2026 along with Limited Review Reports. We attached herewith financial result for the half year ended on September 30 2026
Results-Financial Result For The Half Year Ended On September 30 2026
12-Nov-2026 | Source : BSEWe hereby submit the Standalone Unaudited Financial Result for the half year ended on September 30 2026
Board Meeting Intimation for Meeting Of The Board Of Directors Of The Company To Be Held On Thursday November 12 2026.
05-Nov-2026 | Source : BSESpeciality Medicines Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2026 inter alia to consider and approve 1. Unaudited Standalone Financial Results for the half year ended on September 30 2026.
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Sep 2026
Shareholding Compare (%holding) 
Non Institution
None
Held by 0 Schemes
Held by 0 FIIs
Parthkumar Babulal Goyani (21.12%)
Aparna Samir Thakker (7.33%)
51.15%